XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.1
Equity Transactions - Additional Information (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Oct. 06, 2022
Sep. 30, 2022
Feb. 28, 2023
Nov. 30, 2022
Aug. 31, 2022
Jun. 30, 2023
Mar. 31, 2023
Mar. 31, 2023
Equity Transactions                
Employment agreement extension term (in years)               1 year
Warrants                
Equity Transactions                
Number of fully vested warrants granted to purchase shares of common stock     286 286 286      
Exercise price (in dollars per share)     $ 1.79 $ 2.09 $ 3.40      
Consulting expense             $ 183 $ 886
Director                
Equity Transactions                
Shares granted             8,340 20,667
Stock-based compensation expense             $ 11,250 $ 33,750
President                
Equity Transactions                
Number of shares in a quarterly installment to be vested   2,551            
Consulting services                
Equity Transactions                
Shares granted             19,983 50,039
Stock-based compensation expense             $ 27,000 $ 81,000
Subsequent event                
Equity Transactions                
Non-cash compensation expense, balance amount to be recognized           $ 10,931    
Number of remaining shares to be vested           2,551    
Scientific Advisory Board Common Stock Warrants                
Equity Transactions                
Warrants and Rights Outstanding, Valuation Technique             us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:ValuationTechniqueOptionPricingModelMember
Series A Preferred Stock | President                
Equity Transactions                
Shares granted 10,204              
Non-cash compensation expense             $ 10,930 $ 32,790
Series A Preferred Stock | Employee compensation                
Equity Transactions                
Shares granted             1,727 2,501
Fair Value             $ 6,303 $ 11,362
Stock issuance expense             $ 6,303 $ 11,362